Cortechs.ai Awarded Million Dollar NIH Grant for Early Diagnosis of Alzheimer's Disease Using Advanced Diffusion MRI Technique
Summary
The grant will allow Cortechs.ai to deliver an automated AI solution in a clinical setting to enable physicians to quickly determine a patients risk of developing AD and monitor disease progression and response to treatment. "We are thrilled to receive support from the NIA to further advance this promising technology in the area of Alzheimers Disease diagnosis," said Nathan White, CTO of Cortechs.ai and co-inventor of Restriction Spectrum Imaging. "Alzheimers Disease, a progressive neurodegenerative disorder, is characterized by -amyloid deposits and neurofibrillary tangles preceding neuronal loss and cognitive decline. The project aims to use an advanced diffusion MRI technique called Restriction Spectrum Imaging to quantify the subtle microstructural changes in Alzheimers patients brains, making it possible to detect pathological changes in the brain without an autopsy.Cortechs Labs holds the patent on "Restriction Spectrum Imaging." The project titled "Quantifying microstructural changes in Alzheimers Disease using Restriction Spectrum Imaging" is one of many projects for which Cortechs.ai received research grants.Cortechs.ai develops and markets breakthrough medical device software solutions capable of automatically segmenting and quantifying brain structures, making quantitative analysis of the human brain a routine part of clinical practice.